AGO1 | Argonaute 1, Blocking peptide

AS09 527P | Blocking peptide

Product Information

Format

Lyophilized

Quantity 100 µg

Reconstitution For reconstitution please add sterile water

Storage Store lyophilized/reconstituted at -20°C; once reconstituted make aliquots to avoid repeated freeze-thaw cycles. Please, remember to spin tubes briefly prior to opening them to avoid any losses that might occur from lyophilized material adhering to the cap or sides of the tubes.

Tested applications Neutralization assay (NeA)

Expected | apparent MW

1716.9 Da

Reactivity

Application examples

Additional information

Estimation of the ratio between antibodies and peptide : In neutralisation assay use 9,16 µg of argonaute 1 peptide for 10 ml of reaction volume.

In case of any questions please contact [email protected]

Due to its low molecular weight, this peptide is not suitable for separation on a SDS gel.

Related products

AS09 527 | AGO1 | argonaute 1, rabbit antibodies
AS09 527-HRP | AGO1 | argonaute 1 (40 µg, HRP-conjugated), rabbit antibodies
AS09 527-ALP | AGO1 | argonaute 1 (40 µg, ALP-conjugated), rabbit antibodies
AS09 527B | AGO1 | argonaute 1 (40 µg, Biotin conjugated), rabbit antibodies

AS09 617 | AGO4 argonaute 4, rabbit antibodies
AS10 672 | AGO6 | argonaute 6, rabbit antibodies
AS10 673 | AGO9 | argonaute 9, rabbit antibodies

collection of antibodies to micro RNA

Background

This blocking peptide can be used as a control to neutralize AGO1 | argonaute 1 before immunolocalization or western blot. Furter details are provided below.

AGO1 belongs to a group of argonaute proteins which are catalytic component of the RNA-incudes silencing complex (RISC). This protein complex is responsible for the gene silencing (RNAi).